| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.092 | 0.05 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.083 | 0.06 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.098 | 0.06 |